A multicenter observational study of a new metal stent with Anti-Reflux valve in patients with resectable or borderline resectable pancreatic cancer and obstructive jaundice during neoadjuvant treatment.

A multicenter observational study of a new metal stent with Anti-Reflux valve in patients with resectable or borderline resectable pancreatic cancer and obstructive jaundice during neoadjuvant treatment. - A multicenter observational study of a new metal stent with Anti-Reflux valve in patients with resectable or borderline resectable pancreatic cancer and obstructive jaundice during neoadjuvant treatment.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044211

Enrollment

Registered

2021-05-14

Start date

2019-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Resectable or borderline resectable pancreatic ductal carcinoma case with bile duct stenosis (image diagnosis) Cases planed NAC(R)T

Exclusion criteria

Exclusion criteria: Patients with performance status 4 Severe neurologic impairment or mental disorder with severe other organ disorder Pregnant or lactating women, Cases in which endoscopic biliary drainage is impossible

Design outcomes

Primary

Measure	Time frame
Stent patency rate	—

Secondary

Measure	Time frame
Cholangitis incidence tecnical success rate Adverse event	—

Countries

Japan

Contacts

Public ContactMakoto Hinokuchi

Kagoshima University Graduate School of Medical and Dental Sciences Digestive and Lifestyle Diseases

m-hino@m.kufm.kagoshima-u.ac.jp0992755326

Outcome results